LTD.;SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE CO.
发明人:
Jingan YANG,Zhiguo WANG,Jing CUI,Xiaorou LIU
申请号：
US16330337
公开号：
US20190224201A1
申请日:
2017.09.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A pharmaceutical composition including neptinib is provided. The composition includes neptinib or a pharmaceutically acceptable salt thereof, and an excipient at a low risk of compatibleness. Furthermore, the pharmaceutical composition of the present invention may also include pharmaceutically acceptable organic acid or inorganic acid as a stabilizer. The content of impurity A maintains a non-significant increase in the long-term and accelerated stability investigation for the pharmaceutical composition.
